Identifying the safety profile of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in anticipation of a phase I clinical trial in patients with recurrent ovarian cancer.
about
Progress and problems with the use of suicide genes for targeted cancer therapyGenetic incorporation of human metallothionein into the adenovirus protein IX for non-invasive SPECT imagingA phase I clinical trial of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in patients with recurrent gynecologic cancerStudy of the efficacy, biodistribution, and safety profile of therapeutic gutless adenovirus vectors as a prelude to a phase I clinical trial for glioblastoma.Chapter two--Adenovirus strategies for tissue-specific targeting.A new generation of serotype chimeric infectivity-enhanced conditionally replicative adenovirals: the safety profile of ad5/3-Δ24 in advance of a phase I clinical trial in ovarian cancer patients.Somatostatin receptor based imaging and radionuclide therapy.Bifidobacterial recombinant thymidine kinase-ganciclovir gene therapy system induces FasL and TNFR2 mediated antitumor apoptosis in solid tumorsOncolytic virotherapy with modified adenoviruses and novel therapeutic targets.Tropism-modification strategies for targeted gene delivery using adenoviral vectors.Noninvasive optical imaging of nitroreductase gene-directed enzyme prodrug therapy system in living animals.Somatostatin receptor type 2 as a radiotheranostic PET reporter gene for oncologic interventions.
P2860
Q28262370-7EF516F0-664C-4154-9AA4-77D50ACA4032Q28742934-0E6172F0-12D8-4204-9B8D-01F14A4B227DQ33786353-D5EC166A-83A2-4BF0-A1B9-526DCA93D86EQ34012284-A86CB136-180C-45B7-845B-58A2BDF2A563Q34643252-3F89BC6C-FB91-452D-9121-2D4DDEBF9598Q35101968-24407612-A265-481F-8673-670E6E6F2207Q35296661-06E069FD-92B7-48E1-B9C9-505A73C60B06Q36087611-69688371-689E-4F26-927B-3CFE37614B1EQ38033591-FA40784C-838C-4241-A871-9C09EF8B94CFQ38614156-D97FC0DA-54C3-493B-8DFA-572150CB3A4DQ39507151-9D72CB11-B920-447E-86DD-367A3952D710Q55379548-6F513C3E-109D-499F-86CA-90FD528FFFF8
P2860
Identifying the safety profile of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in anticipation of a phase I clinical trial in patients with recurrent ovarian cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Identifying the safety profile ...... with recurrent ovarian cancer.
@en
Identifying the safety profile ...... with recurrent ovarian cancer.
@nl
type
label
Identifying the safety profile ...... with recurrent ovarian cancer.
@en
Identifying the safety profile ...... with recurrent ovarian cancer.
@nl
prefLabel
Identifying the safety profile ...... with recurrent ovarian cancer.
@en
Identifying the safety profile ...... with recurrent ovarian cancer.
@nl
P2093
P50
P921
P1476
Identifying the safety profile ...... with recurrent ovarian cancer.
@en
P2093
Baohong Tian
Karen Schweikart
Kellie Matthews
Mack N Barnes
Minghui Wang
Patricia E Noker
Raymond Harris
Ronald D Alvarez
Ronna Fulton
Rose Aurigemma
P304
P356
10.1158/1078-0432.CCR-08-3354
P407
P577
2009-06-09T00:00:00Z